AM80
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AM80, covering 2025-08-14 to 2025-08-14. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial of AM80 in Combination With Gemcitabine, Cisplatin, and Nivolumab in Patients With Urothelial Carcinoma [Phase 2]